At home in Southern Germany, the passionate stock exchange expert has been accompanying the capital markets for about twenty years. With a soft spot for smaller companies, he is constantly on the lookout for exciting investment stories. That it depends thereby less on large names, but on the future potential and whether the market also recognizes these perspectives, was one of its first learnings at the stock exchange.
On these pages, Nico examines current events at listed companies and takes a closer look at companies that are traded under the radar of the market, in addition to well-known securities.
In order to be able to take advantage of speculative opportunities on the stock exchange, Nico not only focuses on a balanced asset allocation of defensive and opportunity-oriented securities, but also on an intact risk management. "In addition to position size and entry in several tranches, investors should also develop a sense of timing and get to know a stock better before investing," says the columnist.
Commented by Nico Popp
Commented by Nico Popp on March 18th, 2021 | 06:00 CET
Walt Disney, wallstreet:online, ProSiebenSat.1 Media
What to do in the partial lockdown? People are increasingly asking for content to stay up to date or have some entertainment in dreary times. Whether it's video streaming, TV or reporting on the financial markets - the media industry is currently on the up. But to ensure that this does not remain a short-term corona effect, it is crucial to have promising business models. We present three shares and do the future check.
Read
Commented by Nico Popp on March 17th, 2021 | 07:25 CET
Fresenius SE, Q+M Dental Group, Siemens Healthineers: Where growth meets dividends
The back-and-forth surrounding AstraZeneca's vaccine has unsettled many people. But the discussion about extremely rare side effects also shows: Vaccines and drugs are subject to strict regulations and the healthcare system is strictly regulated. While pharmaceutical companies must always expect setbacks, especially in accelerated approval procedures, the situation is different for suppliers of medical technology or consumables. We present three stocks that are benefiting from rising healthcare spending.
Read
Commented by Nico Popp on March 16th, 2021 | 07:08 CET
BYD, Almonty Industries, Varta: Comebacks and insider tips
Shares related to electromobility and hydrogen have recently shown that trees do not grow to the sky on the stock market. Many a stock that was highly praised just months ago has since lost half its value. At the same time, however, it is clear that the trend toward new drive technologies will continue. In the fourth quarter of 2020, around one-fifth of newly registered vehicles in Germany were hybrids and pure electric cars. Reason enough to look at stocks that could still have potential now.
Read
Commented by Nico Popp on March 15th, 2021 | 07:20 CET
Bitcoin Group, Osino Resources, Newmont: Inflation winners for the portfolio
Despite rising inflation and climbing energy prices, the European Central Bank is sticking to its ultra-loose course and will be even more involved in the bond market in the future than it already is. In this way, the monetary guardians want to recapture rising yields and improve companies and governments' refinancing conditions. While this is understandable in view of the crisis, it could be too much of a good thing as early as the second half of 2021. If the economy picks up again after the lockdowns and people enjoy their lives without restrictions for the first time in more than a year, inflation could loom. We present three stocks that many investors believe hold value and explain what is in them.
Read
Commented by Nico Popp on March 15th, 2021 | 07:14 CET
Interview with PsyBio CEO: Biotech newcomer tackles mental illnesses
The U.S. biotech company PsyBio is focusing on active ingredients to combat depression and other mental illnesses. To this end, it is conducting research around psilocybin, an active ingredient derived from so-called magic mushrooms, which the company can produce itself inexpensively thanks to specially developed and patented processes using bacteria. Co-founder and CEO Evan Levine is certain that these active ingredients have what it takes to revolutionize the market for psychotropic drugs and bring great benefits to patients.
Read
Commented by Nico Popp on March 12th, 2021 | 08:43 CET
Barrick Gold, Scottie Resources, Yamana Gold: Not only gold shines here
Quite a few market observers expect commodities to be at the beginning of a new supercycle. Recent inflation data also suggests that commodity prices will continue to rise. According to some observers, if inflation picks up speed in times of global lockdowns, this must be a significant signal for the post-crisis period. Indeed, the world is poised for a major return to normalcy in the second half of 2021. We highlight stocks that already look promising given this starting point.
Read
Commented by Nico Popp on March 11th, 2021 | 08:50 CET
Zalando, RYU Apparel, Aurelius: A comeback is in the air
The stock market is a daily business. What's hot today can be out tomorrow. It is similar in fashion, making it all the more important for investors to keep a cool head and not overinterpret every development. The market often lures us onto the wrong track with its capers. Inexperienced investors in particular then make the wrong decisions. We present three comeback stocks and explain how investors can act.
Read
Commented by Nico Popp on March 10th, 2021 | 09:56 CET
Varta, JinkoSolar, Nevada Copper: This is where speculators find what they are looking for
New technology has turned many things upside down on the stock market in recent years. First, Alphabet, Apple and Facebook conquered the world, and then Tesla, BYD and NIO followed suit. In the wake of these disruptive companies, numerous suppliers are profiting. Investors who think outside the box in time and recognize these profiteers can reap rich profits. We present three companies that operate around new technologies and are in the focus of investors.
Read
Commented by Nico Popp on March 10th, 2021 | 09:27 CET
BioNTech, CureVac, Cardiol Therapeutics: Biotech rockets off the launchpad
We all know that health is the greatest good. But it is only the last year or so that we've become fully aware of the fact that everything changes during a pandemic. Work, family, leisure time - no area of life is not currently under the influence of Covid-19. But even if lockdown fatigue is slowly but surely setting in, investors should remain wide awake. In many sectors, the course is currently being set for the future - especially in the pharmaceutical and biotech industries. Reason enough to take a closer look at these three stocks.
Read
Commented by Nico Popp on March 9th, 2021 | 07:20 CET
Nornickel, Kodiak Copper, BHP Billiton: From general stores to specialists
While precious metals have been consolidating for months, copper prices continue to climb. Most recently, copper started a new upward movement at the end of February and is now more expensive than it has been for decades. What is the reason for this? On the one hand, copper has always been a sought-after industrial metal. Whenever investments are made in infrastructure worldwide, copper climbs. At the same time, copper benefits from the high demand from the automotive industry. Every electric car contains around three times more copper than conventional combustion engines. We highlight three stocks that can benefit from the copper boom.
Read